Gut Microbiome and Cardiovascular Risk Reduction: Is It Ready for Prime Time?

Are you curious about the gut microbiome and its potential impact on health? Look no further than this continuing education course led by Christopher Gardner, PhD, Director of Nutrition Studies at the Stanford Prevention Research Center. With a mix of humor and evidence-based science, Gardner delves into the latest studies on the topic and highlight the connection between diet, the gut microbiome, and immune function/inflammation. In a world where commercial companies offer to analyze and report back on someone's microbiome from a stool sample, it's important to understand the plausible health benefits and limitations of such tests. Gardner's engaging approach will help you appreciate the extent to which this exciting new domain in health research is ready for prime time. Don't miss this opportunity to expand your knowledge and gain valuable insights into the hot topic of gut microbiome.

Planned in collaboration with the Cardiovascular Health and Well-being DPG.

CPE Level: 2
CPEU: 1

Performance Indicators:

• 8.3.6 Keeps abreast of current nutrition and dietetics.
• 4.2.6 Analyzes and synthesizes information and identifies new information, patterns and findings.
• 8.1.2 Applies knowledge of food and nutrition as well as the biological, physical and social sciences in practice.

Learning Objectives

• Identify the most impactful recent research findings regarding diet, gut microbiome, and cardiovascular risk reduction.
• Describe the importance of the differences between prebiotics and probiotics to patients and clients.
• Critically evaluate claims being made by commercial companies who are offering to analyze and provide feedback on the gut microbiome from individual stool samples.

Speaker

Christopher Gardner, PhD, FAHA

Christopher Gardner holds a PhD in Nutrition Science and is the Rehnborg Farquhar Professor of Medicine at Stanford University. For >25 years his research has examined what to eat and what to avoid for optimal health. This includes more than 20 nutrition intervention trials conducted with >2,000 participants. He is also actively involved with the American Heart Association, American Diabetes Association, and Menus of Change collaborative involving scientists, business leaders and chefs, focusing on unapologetically delicious, healthy food. Over the past eight years he has collaborated with the internationally renowned microbiology experts from the Sonnenburg lab at Stanford to conduct multiple diet intervention studies exploring the impact on the gut microbiome, immune function and inflammation.